92 related articles for article (PubMed ID: 9476874)
1. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer.
Wilczynski SW; Erasmus JJ; Petros WP; Vredenburgh JJ; Folz RJ
Am J Respir Crit Care Med; 1998 Feb; 157(2):565-73. PubMed ID: 9476874
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support.
Bhalla KS; Wilczynski SW; Abushamaa AM; Petros WP; McDonald CS; Loftis JS; Chao NJ; Vredenburgh JJ; Folz RJ
Am J Respir Crit Care Med; 2000 Jan; 161(1):17-25. PubMed ID: 10619792
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation.
Todd NW; Peters WP; Ost AH; Roggli VL; Piantadosi CA
Am Rev Respir Dis; 1993 May; 147(5):1264-70. PubMed ID: 8484641
[TBL] [Abstract][Full Text] [Related]
4. Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation.
McGaughey DS; Nikcevich DA; Long GD; Vredenburgh JJ; Rizzieri D; Smith CA; Broadwater G; Loftis JS; McDonald C; Morris AK; Folz RF; Chao NF
Biol Blood Marrow Transplant; 2001; 7(5):274-8. PubMed ID: 11400949
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary function after high-dose chemotherapy with autologous bone marrow transplantation and radiotherapy in patients with advanced loco-regional breast cancer.
Dolsma WV; De Vries EG; Van der Mark TW; Sleijfer DT; Willemse PH; Van Der Graaf WT; Mulder PO; Szabó BG; Mulder NH
Anticancer Res; 1997; 17(1B):537-40. PubMed ID: 9066577
[TBL] [Abstract][Full Text] [Related]
6. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue.
Lind PA; Marks LB; Jamieson TA; Carter DL; Vredenburgh JJ; Folz RJ; Prosnitz LR
Cancer; 2002 Jun; 94(11):2821-9. PubMed ID: 12115368
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support.
Winer EP; Lindley C; Hardee M; Sawyer WT; Brunatti C; Borstelmann NA; Peters W
Psychooncology; 1999; 8(2):167-76. PubMed ID: 10335560
[TBL] [Abstract][Full Text] [Related]
8. Patterns of failure following bone marrow transplantation for metastatic breast cancer: the role of consolidative local therapy.
Shah AB; Hartsell WF; Ghalie R; Kaizer H
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1433-8. PubMed ID: 7635784
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation.
Cao TM; Negrin RS; Stockerl-Goldstein KE; Johnston LJ; Shizuru JA; Taylor TL; Rizk NW; Wong RM; Blume KG; Hu WW
Biol Blood Marrow Transplant; 2000; 6(4):387-94. PubMed ID: 10917574
[TBL] [Abstract][Full Text] [Related]
10. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
[TBL] [Abstract][Full Text] [Related]
11. Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
Peppercorn J; Herndon J; Kornblith AB; Peters W; Ahles T; Vredenburgh J; Schwartz G; Shpall E; Hurd DD; Holland J; Winer E
Cancer; 2005 Oct; 104(8):1580-9. PubMed ID: 16118805
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.
Gisselbrecht C; Extra JM; Lotz JP; Devaux Y; Janvier M; Peny AM; Guillevin L; Bremond D; Delain M; Herbrecht R; Lepage E; Maraninchi D
Bone Marrow Transplant; 1996 Nov; 18(5):857-63. PubMed ID: 8932837
[TBL] [Abstract][Full Text] [Related]
13. Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors.
Brockstein BE; Smiley C; Al-Sadir J; Williams SF
Bone Marrow Transplant; 2000 Apr; 25(8):885-94. PubMed ID: 10808211
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary toxicity of high-dose chemotherapy for breast cancer: a non-invasive approach to diagnosis and treatment.
Chap L; Shpiner R; Levine M; Norton L; Lill M; Glaspy J
Bone Marrow Transplant; 1997 Dec; 20(12):1063-7. PubMed ID: 9466279
[TBL] [Abstract][Full Text] [Related]
15. High-dose carmustine, etoposide and melphalan ('BEM') with autologous stem cell transplantation: a dose-toxicity study.
Ager S; Mahendra P; Richards EM; Bass G; Baglin TP; Marcus RE
Bone Marrow Transplant; 1996 Mar; 17(3):335-40. PubMed ID: 8704683
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens.
Seiden MV; Elias A; Ayash L; Hunt M; Eder JP; Schnipper LE; Frei E; Antman KH
Bone Marrow Transplant; 1992 Jul; 10(1):57-63. PubMed ID: 1515880
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer.
Wong R; Rondon G; Saliba RM; Shannon VR; Giralt SA; Champlin RE; Ueno NT
Bone Marrow Transplant; 2003 Jun; 31(12):1157-63. PubMed ID: 12796796
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary drug toxicity following high-dose chemotherapy with autologous bone marrow transplantation: CT findings in 20 cases.
Patz EF; Peters WP; Goodman PC
J Thorac Imaging; 1994; 9(2):129-34. PubMed ID: 8207780
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) for the treatment of breast cancer: the jury is still out.
Smith GA; Henderson IC
Important Adv Oncol; 1995; ():201-14. PubMed ID: 7672807
[No Abstract] [Full Text] [Related]
20. High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer.
Tallman MS; Rademaker AW; Jahnke L; Brown SG; Bauman A; Mangan C; Kelly C; Rubin H; Kies MS; Shaw J; Kiel K; Gordon LI; Gradishar WJ; Winter JN
Bone Marrow Transplant; 1997 Nov; 20(9):721-9. PubMed ID: 9384473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
